AI Stock Memo: ADUS - Addus HomeCare - RankAlpha

ADUS

AI Memo

Addus HomeCare

As of 2026-07-24/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-07-24 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q2 2026 earnings release and conference call • 2026-10-22

Expected move: -0%

Biggest risk

Q1 revenue reportedly missed expectations, while labor intensity, staffing, reimbursement uncertainty, CDPAP-related disruption, and limited forward-detail visibility constrain conviction. No analyst revision or target-change data is available.

Invalidation

Break below $101 or thesis failure.

What would change my mind?

Positive deterministic priors, recurring home-based care demand, reported year-over-year Q1 growth, and potential focus benefits from the New York divestiture support a cautiously constructive view.

Research note

Recommendation

—

Confidence

medium

As of

2026-07-24

Base target

$115

p=50%

Bull target

$133

p=25%

Bear target

$101

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-Q1 earnings digestion
New York personal-care divestiture execution
Positive deterministic priors, recurring home-based care demand, reported year-over-year Q1 growth, and potential focus benefits from the New York divestiture support a cautiously constructive view.

BearKey bullets

Labor costs, staffing shortages, and reimbursement or regulatory changes could pressure margins.
New York CDPAP uncertainty and divestiture execution may disrupt operations or cash flows [#SEC-10Q-2026-05-05].
Peer comparability is loose and does not provide a strong relative-valuation anchor.

WatchKey bullets

Q2 2026 earnings release and conference call

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $115 (p=50%)

Bull/Bear spread: +15% / -13%

Vs latest close: Bull +15% · Base -0% · Bear -13%

Scenario probabilities

Bull Target: $133 (p=25%)Base Target: $115 (p=50%)Bear Target: $101 (p=25%)

Commentary

News flow is moderately active around Q1 results and the upcoming Q2 reporting cycle, but the available earnings recap was secondary and revision data is unavailable. The primary SEC 8-K confirms that Addus reported Q1 results on May 4, 2026 [#SEC-8K-2026-05-04]. Overall sentiment is mildly positive, with insufficient forward evidence for a high-conviction upgrade.

As of 2026-07-24 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Positive deterministic priors, recurring home-based care demand, reported year-over-year Q1 growth, and potential focus benefits from the New York divestiture support a cautiously constructive view.

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-Q1 earnings digestion
New York personal-care divestiture execution

Scenarios

Bull Target (Scenario probability)

$133 / p=25% prob

Base Target (Scenario probability)

$115 / p=50% prob

Bear Target (Scenario probability)

$101 / p=25% prob

Price $115 as of 2026-07-31

Nearest Scenario: Base (∆ 0%)

Targets vs latest close: Bull +15% · Base -0% · Bear -13%

Sentiment & Exposure

News Sentiment (30d)

0.10

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-22
Q2 2026 earnings release and conference call
A July 20 company earnings announcement is listed in the packet, but the exact release and call date is not provided. Results, guidance, labor costs, reimbursement trends, and service volumes are the next material validation points.
Prob 70.00% • Move 4.50% • Priced-in 40.00%

Short-term Catalysts

Next few weeks

Post-Q1 earnings digestion
2026-10-22
Stored earnings context reports Q1 revenue of $363.6 million, up 7.7% year over year but 0.7% below expectations; the shares were nevertheless reported higher after the print. The signal is constructive but not decisive.
Prob 55% • Move 3% • Priced-in 70%

Long-term Catalysts

Months to a year

New York personal-care divestiture execution
2027-07-24
The 2026 10-Q states that uncertainty around New York CDPAP led the company to conclude that its New York personal-care operations no longer fit its growth strategy and that it is divesting them [#SEC-10Q-2026-05-05]. Successful execution could improve strategic focus, but proceeds, transition costs, and operating impact remain unclear.
Prob 60% • Move 3% • Priced-in 50%

Risks

Labor costs, staffing shortages, and reimbursement or regulatory changes could pressure margins.
New York CDPAP uncertainty and divestiture execution may disrupt operations or cash flows [#SEC-10Q-2026-05-05].
Peer comparability is loose and does not provide a strong relative-valuation anchor.
Q1 revenue reportedly came in modestly below expectations.
The packet lacks current guidance detail, analyst estimate revisions, target changes, and insider or social-sentiment confirmation.

Peers

Symbol	Summary
ASTH	Same-sector, similar-market-cap candidate; the packet does not establish close operating comparability to Addus.
AXGN	Same-sector, similar-market-cap candidate; direct business overlap is not established in the packet.
HTFL	Same-sector, similar-market-cap candidate; peer fit and operating metrics are unavailable.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-07-24